These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27257850)

  • 1. The Fontan epidemic: Population projections from the Australia and New Zealand Fontan Registry.
    Schilling C; Dalziel K; Nunn R; Du Plessis K; Shi WY; Celermajer D; Winlaw D; Weintraub RG; Grigg LE; Radford DJ; Bullock A; Gentles TL; Wheaton GR; Hornung T; Justo RN; d'Udekem Y
    Int J Cardiol; 2016 Sep; 219():14-9. PubMed ID: 27257850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redefining expectations of long-term survival after the Fontan procedure: twenty-five years of follow-up from the entire population of Australia and New Zealand.
    d'Udekem Y; Iyengar AJ; Galati JC; Forsdick V; Weintraub RG; Wheaton GR; Bullock A; Justo RN; Grigg LE; Sholler GF; Hope S; Radford DJ; Gentles TL; Celermajer DS; Winlaw DS
    Circulation; 2014 Sep; 130(11 Suppl 1):S32-8. PubMed ID: 25200053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three decades later: The fate of the population of patients who underwent the Atriopulmonary Fontan procedure.
    Poh CL; Zannino D; Weintraub RG; Winlaw DS; Grigg LE; Cordina R; Hornung T; Bullock A; Justo RN; Gentles TL; Verrall C; du Plessis K; Celermajer DS; d'Udekem Y
    Int J Cardiol; 2017 Mar; 231():99-104. PubMed ID: 28100430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Australia and New Zealand Fontan Registry: description and initial results from the first population-based Fontan registry.
    Iyengar AJ; Winlaw DS; Galati JC; Gentles TL; Weintraub RG; Justo RN; Wheaton GR; Bullock A; Celermajer DS; d'Udekem Y
    Intern Med J; 2014 Feb; 44(2):148-55. PubMed ID: 24393144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in Fontan surgery and risk factors for early adverse outcomes after Fontan surgery: the Australia and New Zealand Fontan Registry experience.
    Iyengar AJ; Winlaw DS; Galati JC; Celermajer DS; Wheaton GR; Gentles TL; Grigg LE; Weintraub RG; Bullock A; Justo RN; d'Udekem Y
    J Thorac Cardiovasc Surg; 2014 Aug; 148(2):566-75. PubMed ID: 24280718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Outcomes in Adolescents and Adults After the Fontan Procedure.
    Dennis M; Zannino D; du Plessis K; Bullock A; Disney PJS; Radford DJ; Hornung T; Grigg L; Cordina R; d'Udekem Y; Celermajer DS
    J Am Coll Cardiol; 2018 Mar; 71(9):1009-1017. PubMed ID: 29495980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart transplantation in Fontan patients across Australia and New Zealand.
    Shi WY; Yong MS; McGiffin DC; Jain P; Ruygrok PN; Marasco SF; Finucane K; Keogh A; d'Udekem Y; Weintraub RG; Konstantinov IE
    Heart; 2016 Jul; 102(14):1120-6. PubMed ID: 27000055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twenty-Five Year Outcomes of the Lateral Tunnel Fontan Procedure.
    Wilson TG; Shi WY; Iyengar AJ; Winlaw DS; Cordina RL; Wheaton GR; Bullock A; Gentles TL; Weintraub RG; Justo RN; Grigg LE; Radford DJ; d'Udekem Y;
    Semin Thorac Cardiovasc Surg; 2017 Autumn; 29(3):347-353. PubMed ID: 29195575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unsatisfactory Early and Late Outcomes After Fontan Surgery Delayed to Adolescence and Adulthood.
    Forsdick V; Iyengar AJ; Carins T; Gentles TL; Weintraub RG; Celermajer DS; d'Udekem Y
    Semin Thorac Cardiovasc Surg; 2015; 27(2):168-74. PubMed ID: 26686444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The extracardiac conduit Fontan procedure in Australia and New Zealand: hypoplastic left heart syndrome predicts worse early and late outcomes.
    Iyengar AJ; Winlaw DS; Galati JC; Wheaton GR; Gentles TL; Grigg LE; Justo RN; Radford DJ; Weintraub RG; Bullock A; Celermajer DS; d'Udekem Y;
    Eur J Cardiothorac Surg; 2014 Sep; 46(3):465-73; discussion 473. PubMed ID: 24578409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modes of late mortality in patients with a Fontan circulation.
    Poh C; Hornung T; Celermajer DS; Radford DJ; Justo RN; Andrews D; du Plessis K; Iyengar AJ; Winlaw D; d'Udekem Y
    Heart; 2020 Sep; 106(18):1427-1431. PubMed ID: 32098807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pacemakers are associated with a higher risk of late death and transplantation in the Fontan population.
    Poh CL; Celermajer DS; Grigg LE; Kalman JM; McGuire MA; Gentles TL; Radford DJ; Bullock A; Disney PJS; Winlaw D; du Plessis K; d'Udekem Y
    Int J Cardiol; 2019 May; 282():33-37. PubMed ID: 30755335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of ACE inhibitors in Fontan: Rational or irrational?
    Wilson TG; Iyengar AJ; Winlaw DS; Weintraub RG; Wheaton GR; Gentles TL; Ayer J; Grigg LE; Justo RN; Radford DJ; Bullock A; Celermajer DS; Dalziel K; Schilling C; d'Udekem Y;
    Int J Cardiol; 2016 May; 210():95-9. PubMed ID: 26938683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic and renal end-organ damage in the Fontan circulation: A report from the Australian and New Zealand Fontan Registry.
    Wilson TG; d'Udekem Y; Winlaw DS; Cordina RL; Celermajer DS; Wheaton GR; Bullock A; Gentles TL; Weintraub RG; Justo RN; Grigg LE; Radford DJ; Hardikar W; Cheung M; Cain TM; Rao P; Alexander SI; Ayer J; Verrall C; Du Plessis K; Chapman J; Rice K; Barry J; Zannino D; Iyengar AJ;
    Int J Cardiol; 2018 Dec; 273():100-107. PubMed ID: 30060970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten-year outcomes of Fontan conversion in Australia and New Zealand demonstrate the superiority of a strategy of early conversion.
    Poh CL; Cochrane A; Galati JC; Bullock A; Celermajer DS; Gentles T; du Plessis K; Winlaw DS; Hornung T; Finucane K; d'Udekem Y
    Eur J Cardiothorac Surg; 2016 Feb; 49(2):530-5; discussion 535. PubMed ID: 25838458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fertility and pregnancy in the Fontan population.
    Zentner D; Kotevski A; King I; Grigg L; d'Udekem Y
    Int J Cardiol; 2016 Apr; 208():97-101. PubMed ID: 26836494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "How long will I continue to be normal?" Adults with a Fontan circulation's greatest concerns.
    du Plessis K; Peters R; King I; Robertson K; Mackley J; Maree R; Stanley T; Pickford L; Rose B; Orchard M; Stewart H; d'Udekem Y
    Int J Cardiol; 2018 Jun; 260():54-59. PubMed ID: 29622455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospital Inpatient Costs for Single Ventricle Patients Surviving the Fontan Procedure.
    Huang L; Schilling C; Dalziel KM; Xie S; Celermajer DS; McNeil JJ; Winlaw D; Hornung TS; Radford DJ; Grigg LE; Bullock A; Wheaton GR; Justo RN; Blake J; Bishop R; Du Plessis K; d'Udekem Y
    Am J Cardiol; 2017 Aug; 120(3):467-472. PubMed ID: 28583678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry.
    McDonald SP; Russ GR; Kerr PG; Collins JF;
    Am J Kidney Dis; 2002 Dec; 40(6):1122-31. PubMed ID: 12460029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No difference between aspirin and warfarin after extracardiac Fontan in a propensity score analysis of 475 patients.
    Iyengar AJ; Winlaw DS; Galati JC; Wheaton GR; Gentles TL; Grigg LE; Justo RN; Radford DJ; Attard C; Weintraub RG; Bullock A; Sholler GS; Celermajer DS; d'Udekem Y;
    Eur J Cardiothorac Surg; 2016 Nov; 50(5):980-987. PubMed ID: 27229665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.